DePuy Synthes buys TRS’ 3D printing technology for bone defects treatment

This article was originally published here

Johnson & Johnson (J&J) business unit DePuy Synthes Products has acquired 3D printing technology from Tissue Regeneration Systems (TRS) for the treatment of bone defects.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply